Priority Date: 13.12.11 (US 201161569981P)

CHIMERIC THERAPEUTIC ANTI - CD37 ANTIBODIE HH1

  • Application ID: EP12818820
  • Status: EXAMINATION IN PROGRESS

Attorneys

Employment test 51 - 200 employees
Company dna plougmann and vingtoft
operating since 1967
Headquarter in Copenhagen and 5 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service
Employment test 1 - 10 employees
Company dna copa copenhagen patents ks
operating since 2012
Headquarter in Copenhagen and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Plougmann & Vingtoft A/S is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.12.2011 - Priority Date (US 201161569981P)
  • 20.06.2013 - Publication A1 (WO2013088363)
  • 22.10.2014 - Publication A1 (EP2790740)

IPC Classification